With every new breakthrough at Penn's Abramson Cancer Center, we're discovering that the cure for cancer isn't just within reach, it's within us all.
New $21 million gift from Mindy and Jon Gray cements Basser Center for BRCA as a leader in advancing the fight against hereditary cancers.
If accepted, the treatment will be the first gene therapy ever to reach the market. And it was developed here at Penn Medicine by Carl June, MD, and his team.
We are pleased to share that cancer immunotherapy and translational research expert Robert Vonderheide, MD, DPhil, has been named Director of the Abramson Cancer Center.
We are ranked highest in the Philadelphia region and 12th in the nation for cancer care by U.S. World & News Report.
Clinical trials help cancer survivors live longer and have a better quality of life through new ways to detect, diagnose and treat cancer.
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.